391711008: Acipimox (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Antilipemic agent (substance)\Acipimox

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrazine (substance)\Acipimox

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2693689015 Acipimox en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2734134013 Acipimox (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

60151000195118 acipimox it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

789031000172112 acipimox fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

75561000195112 Acipimox de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Acipimox	Is a	Antilipemic agent (substance)	true	Inferred relationship	Some
Acipimox	Is a	Pyrazine (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Allergy to acipimox (finding)	Causative agent (attribute)	False	Acipimox	Inferred relationship	Some
Acipimox 250 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Acipimox	Inferred relationship	Some
Acipimox product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Acipimox	Inferred relationship	Some
Product containing acipimox (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Acipimox	Inferred relationship	Some	1
Acipimox adverse reaction	Causative agent (attribute)	True	Acipimox	Inferred relationship	Some	1
Allergy to acipimox (finding)	Causative agent (attribute)	True	Acipimox	Inferred relationship	Some	1
Acipimox 250 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Acipimox	Inferred relationship	Some	1
Acipimox 250 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Acipimox	Inferred relationship	Some	1
Product containing acipimox in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Acipimox	Inferred relationship	Some	1
Acipimox 250 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Acipimox	Inferred relationship	Some	1
Acipimox only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Acipimox	Inferred relationship	Some	1
Acipimox only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Acipimox	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set